| Name | Litifilimab |
|---|
| Description | Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study[1][2]. |
|---|---|
| Related Catalog | |
| Target |
C-type lectin domain family 4 member C, CLEC4C |
| References |
| No Any Chemical & Physical Properties |